HutchMed aims to establish a bigger presence in the city when the first wet laboratories at the much larger Hong…
Read More »pharmaceutical
China’s biotechnology merger and acquisition (M&A) transactions have almost doubled this year, with interest perking up among investors amid a…
Read More »
Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…
Read More »
The dietary supplement producer, established in 2004, spent 2 billion yuan (US$294 million) to build a factory this year in…
Read More »
Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to…
Read More »
Novoheart Holdings, the inventor of artificial “mini-hearts” co-founded by a Hong Kong scientist, is expanding its research and manufacturing budget…
Read More »
An MSCI index tracking 81 Chinese health care stocks with a combined market value of HK$1.15 trillion (US$148 billion) advanced…
Read More »